FindTrial
Sign In

The Multimorbid Geriatric Cancer Patient – Therapy and Quality of Life A Multicenter Study to Develop, Modulate and Pilot-test a Patient-centered Interdisciplinary Care Concept for Geriatric Oncology Patients

The Multimorbid Geriatric Cancer Patient – Therapy and Quality of Life A Multicenter Study to Develop, Modulate and Pilot-test a Patient-centered Interdisciplinary Care Concept for Geriatric Oncology Patients - PIVOG

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00007607
Enrollment
100
Registered
2014-12-09
Start date
2014-11-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oncologic diseases in geriatric patients C00-C97

Interventions

Group 1: In addition to standardized medical assessments according to clinical guidelines comprehensive geriatric assessment, bilogical age (AGE-Reader) and patient reported quality of life will be ta

Sponsors

Wilhelm-Roux-Förderprogramm der Medizinischen Fakultät der Martin-Luther-Universität Halle-Wittenberg, Prodekanat Forschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: Oncologic patients 70 years and older receiving in-patient or out-patient treatment with at least one comorbidity and/or one functional impairment regarding ADL, with written informed consent given by patients and, if necessary, their legal custodian.

Exclusion criteria

Exclusion criteria: unsufficient language proficiency, severe psychiatric comorbidity or severe dementia that preclude answering questionnaires

Design outcomes

Primary

MeasureTime frame
HRQoL (health-related quality of life) (EORTC QLQ-C30, ELD14) 6 months after dismissal from hospital (t3 Follow-up) in comparison to admission (t1). Presumed clinical relevand difference of 10 pts. of the scale from 0/100.—

Secondary

MeasureTime frame
6 months after dismissal (t3) number and reason of readmissions (during follow-up), overall and disease specific survival, patient satisfaction (7 questions likert scale)—

Countries

Germany

Contacts

Public ContactHeike Schmidt

Institut für Gesundheits- und Pflegewissenschaft, Medizinische Fakultät der MLU Halle-Wittenberg

heike.schmidt2@uk-halle.de0345 5574194

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026